ORBIMED ADVISORS LLC 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-08 4:34 pm Sale |
2024-03-06 | 13D | NextCure, Inc. NXTC |
ORBIMED ADVISORS LLC | 1,268,013 4.500% |
-1,443,000 (-53.23%) |
Filing |